FDA efficiency for approval process of COVID-19 therapeutics

Coronavirus disease 19 (COVID-19) is an infection caused by the novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The pandemic spread of SARS-CoV-2 has resulted in significant health, economic, and social ramifications. There are no U.S. Food and Drug Administration (FDA)-approved...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassidy, Christine, Dever, Danielle, Stanbery, Laura, Edelman, Gerald, Dworkin, Lance, Nemunaitis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705854/
https://www.ncbi.nlm.nih.gov/pubmed/33292374
http://dx.doi.org/10.1186/s13027-020-00338-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705854/
https://www.ncbi.nlm.nih.gov/pubmed/33292374
http://dx.doi.org/10.1186/s13027-020-00338-z

Ejemplares similares